RECRUITING

Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Groups of unimpaired participants will all receive speech motor training of nonwords, and six tDCS conditions will be compared: anodal tDCS over speech motor regions; cathodal tDCS over speech motor regions; anodal tDCS over left frontal regions; cathodal tDCS over left frontal regions; cathodal stimulation over non-speech motor regions (anodal already collected);and sham tDCS (no stimulation). This will address a basic science question about whether the mechanism underlying speech motor learning requires premotor and motor cortical regions to be stimulated, which has implications for treatment of acquired speech impairment. The primary outcome measure will be the difference in production accuracy and changes in motor acuity (measured with duration) of novel consonant cluster production.

Official Title

Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning

Quick Facts

Study Start:2022-10-25
Study Completion:2026-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05804344

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 35 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * native English speaker (learned English in the home from birth)
  2. * no exposure to languages that contain the trained consonant clusters (e.g., Slavic languages, Greek, Hebrew).
  1. * a history of speech, language or hearing disorder
  2. * not passing a hearing screening (40 dB HL; ANSI: 1983) at 500, 1000, 2000, 4000Hz binaurally
  3. * presence of potential tDCS risk factors: damaged skin at site of stimulation; presence of electrically or magnetically activated implant (including pacemaker); and metal in any part of their body

Contacts and Locations

Study Contact

Adam Buchwald, Phd
CONTACT
2129985260
buchwaldlab.nyu@gmail.com

Principal Investigator

Adam Buchwald, PhD
PRINCIPAL_INVESTIGATOR
New York University

Study Locations (Sites)

New York University Department of Communicative Sciences and Disorders
New York, New York, 10012
United States

Collaborators and Investigators

Sponsor: New York University

  • Adam Buchwald, PhD, PRINCIPAL_INVESTIGATOR, New York University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-25
Study Completion Date2026-03-01

Study Record Updates

Study Start Date2022-10-25
Study Completion Date2026-03-01

Terms related to this study

Additional Relevant MeSH Terms

  • Healthy